Your browser doesn't support javascript.
loading
Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision.
Mackintosh, John A; Keir, Gregory; Troy, Lauren K; Holland, Anne E; Grainge, Christopher; Chambers, Daniel C; Sandford, Debra; Jo, Helen E; Glaspole, Ian; Wilsher, Margaret; Goh, Nicole S L; Reynolds, Paul N; Chapman, Sally; Mutsaers, Steven E; de Boer, Sally; Webster, Susanne; Moodley, Yuben; Corte, Tamera J.
Afiliação
  • Mackintosh JA; Department of Respiratory Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia.
  • Keir G; Centre of Research Excellence in Pulmonary Fibrosis, Camperdown, New South Wales, Australia.
  • Troy LK; Department of Respiratory Medicine, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Holland AE; Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
  • Grainge C; University of Sydney, Sydney, New South Wales, Australia.
  • Chambers DC; Centre of Research Excellence in Pulmonary Fibrosis, Camperdown, New South Wales, Australia.
  • Sandford D; Department of Physiotherapy, The Alfred Hospital, Melbourne, Victoria, Australia.
  • Jo HE; Department of Respiratory Research@Alfred, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Glaspole I; Department of Respiratory Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia.
  • Wilsher M; Department of Respiratory Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia.
  • Goh NSL; Centre of Research Excellence in Pulmonary Fibrosis, Camperdown, New South Wales, Australia.
  • Reynolds PN; Centre of Research Excellence in Pulmonary Fibrosis, Camperdown, New South Wales, Australia.
  • Chapman S; Department of Thoracic Medicine, Central Adelaide Local Health Network, Adelaide, South Australia, Australia.
  • Mutsaers SE; University of Adelaide, Adelaide, South Australia, Australia.
  • de Boer S; Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
  • Webster S; University of Sydney, Sydney, New South Wales, Australia.
  • Moodley Y; Centre of Research Excellence in Pulmonary Fibrosis, Camperdown, New South Wales, Australia.
  • Corte TJ; Department of Respiratory Medicine, The Alfred Hospital, Melbourne, Victoria, Australia.
Respirology ; 29(2): 105-135, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38211978
ABSTRACT
Idiopathic pulmonary fibrosis (IPF) is a progressive disease leading to significant morbidity and mortality. In 2017 the Thoracic Society of Australia and New Zealand (TSANZ) and Lung Foundation Australia (LFA) published a position statement on the treatment of IPF. Since that time, subsidized anti-fibrotic therapy in the form of pirfenidone and nintedanib is now available in both Australia and New Zealand. More recently, evidence has been published in support of nintedanib for non-IPF progressive pulmonary fibrosis (PPF). Additionally, there have been numerous publications relating to the non-pharmacologic management of IPF and PPF. This 2023 update to the position statement for treatment of IPF summarizes developments since 2017 and reaffirms the importance of a multi-faceted approach to the management of IPF and progressive pulmonary fibrosis.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Idiopática Limite: Humans País/Região como assunto: Oceania Idioma: En Revista: Respirology Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Idiopática Limite: Humans País/Região como assunto: Oceania Idioma: En Revista: Respirology Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália